4D Molecular Therapeutics (FDMT) Q3 2025 Earnings

11AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.98
-0.88
-0.78
-0.68

Details

Expected EPS
-0.727273
Actual EPS
-0.98
Surprise EPS
-0.25
Surprise Percent
+34.75%

Description

4D Molecular Therapeutics (FDMT) has reported earnings of -0.98 per share for Q3 2025.

0 Comments

Share your thoughts